Promoting DNA alkylation of hypoxia-activated molecular prodrug for cooperative precision photodynamic-chemotherapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer10.1038/s41586-022-04508-4 ↗
2. Paradoxical effects of DNA tumor virus oncogenes on epithelium-derived tumor cell fate during tumor progression and chemotherapy response10.1038/s41392-021-00787-x ↗
3. Balancing repair and tolerance of DNA damage caused by alkylating agents10.1038/nrc3185 ↗
4. Reactive OFF-ON type alkylating agents for higher-ordered structures of nucleic acids10.1093/nar/gkz512 ↗
5. Electrochemistry of chemo-therapeutic alkylating agents and their interaction with DNA10.1016/j.jpba.2022.115036 ↗
6. Chemotherapy: a double-edged sword in cancer treatment10.1007/s00262-021-03013-3 ↗
7. Supramolecular chemotherapy based on host-guest molecular recognition: a novel strategy in the battle against cancer with a bright future10.1039/C6CS00898D ↗
8. Molecular interactions in organic nanoparticles for phototheranostic applications10.1021/acs.chemrev.5b00140 ↗
9. Liu W., He S., Ma X., Lv C., Gu H., Cao J., Du J., Sun W., Fan J., Peng X. Near-infrared heptamethine cyanine photosensitizers with efficient singlet oxygen generation for anticancer photodynamic therapy. Angew Chem Int Ed 2024;63:e202411802. doi:10.1002/anie.202411802.10.1002/anie.202411802 ↗
10. Single-molecule förster resonance energy transfer-based photosensitizer for synergistic photodynamic/photothermal therapy10.1021/acscentsci.0c01551 ↗
11. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
12. Supramolecular photosensitizer enables oxygen-independent generation of hydroxyl radicals for photodynamic therapy10.1021/jacs.2c11868 ↗
13. Recent advancement in photosensitizers for photodynamic therapy10.1016/j.dyepig.2024.112262 ↗
14. Carrier-free, amorphous verteporfin nanodrug for enhanced photodynamic cancer therapy and brain drug delivery10.1002/advs.202302872 ↗
15. A photosensitizer-inhibitor conjugate for photodynamic therapy with simultaneous inhibition of treatment escape pathways10.1016/j.biomaterials.2020.120262 ↗
16. Structure-inherent targeting of near-infrared fluorophores for parathyroid and thyroid gland imaging10.1038/nm.3728 ↗
17. De novo design of phototheranostic sensitizers based on structure-inherent targeting for enhanced cancer ablation10.1021/jacs.8b09117 ↗
18. A single molecule drug targeting photosensitizer for enhanced breast cancer photothermal therapy10.1002/smll.201907677 ↗
19. Photosensitizers with aggregation‐induced emission: materials and biomedical applications10.1002/adma.201801350 ↗
20. Self-assembled core-shell nanoparticles for combined chemotherapy and photodynamic therapy of resistant head and neck cancers10.1021/nn506963h ↗
21. Nucleus-targeting near-infrared nanoparticles based on TAT peptide-conjugated IR780 for photo-chemotherapy of breast cancer10.1016/j.cej.2019.122458 ↗
22. ROS-responsive camptothecin prodrug nanoparticles for on-demand drug release and combination of chemotherapy and photodynamic therapy10.1002/adfm.202005918 ↗
23. Manganese/iron-based nanoprobes for photodynamic/chemotherapy combination therapy of tumor guided by multimodal imaging10.1039/D0NR08831E ↗
24. Phase-change mediated intelligent nanoplatform for chemo/photothermal/photodynamic therapy of cancer10.1002/adhm.202202245 ↗
25. The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy10.1039/D2CS00673A ↗
26. Redox-programmed theranostic system with instant response: light-triggered methylene blue activation driving self-amplified PDT through glutathione depletion and synergistic chemotherapy10.1016/j.dyepig.2025.112997 ↗
27. Hypoxia-targeted drug delivery10.1039/C8CS00304A ↗
28. Nanomaterials relieving hypoxia for enhanced tumor therapy10.1016/j.ccr.2023.215482 ↗
29. Enhancing the release efficiency of a molecular chemotherapeutic prodrug by photodynamic therapy10.1002/anie.202206169 ↗
30. Near-infrared fluorescent probes for hypoxia detection via joint regulated enzymes: design, synthesis, and application in living cells and mice10.1021/acs.analchem.8b04249 ↗
31. Recent development of chemosensors based on cyanine platforms10.1021/acs.chemrev.6b00001 ↗
32. Design strategies and applications of cyanine dyes in phototherapy10.1039/D3CS00585B ↗
33. Regulating charge transfer in cyanine dyes: a universal methodology for enhancing cancer phototherapeutic efficacy10.1021/acs.accounts.4c00399 ↗
34. Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy10.1039/C9SC03355F ↗
35. The nitrogen mustards10.1124/pharmrev.120.000121 ↗
36. H-aggregates of prodrug-hemicyanine conjugate for enhanced photothermal therapy and sequential hypoxia-activated chemotherapy10.1021/acsmaterialslett.2c00015 ↗
37. Hypoxia-activatable nano-prodrug for fluorescently tracking drug release in mice10.1007/s11426-020-9880-7 ↗
38. NIR photo-sensitizers activated by γ-glutamyl transpeptidase for precise tumor fluorescence imaging and photodynamic therapy10.1007/s11426-020-9947-4 ↗
39. Injectable and sprayable fluorescent nanoprobe for rapid real-time detection of human colorectal tumors
40. Thermoresponsive chlorambucil derivatives for tumour targeting10.1002/anie.201101133 ↗
41. Functional up-grading of an organo-Ir(III) complex to an organo-Ir(III) prodrug as a DNA damage-responsive autophagic inducer for hypoxic lung cancer therapy10.1021/acs.inorgchem.4c00060 ↗
42. Heat induces γH2AX foci formation in mammalian cells10.1016/j.mrgentox.2008.07.012 ↗
43. ROS-responsive mitochondria-targeting blended nanoparticles: chemo- and photodynamic synergistic therapy for lung cancer with on-demand drug release upon irradiation with a single light source10.7150/thno.15433 ↗
44. Heptamethine cyanine-based molecule release triggered by mitochondrial ROS10.1021/acsabm.3c00955 ↗
45. Photodynamic therapy-triggered on-demand drug release from ROS-responsive core-cross-linked micelles toward synergistic anti-cancer treatment10.1007/s12274-019-2330-y ↗